From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 18/10/2017 to: 18/10/2017 ESO Breast Cancer Observatory, Tehran, Iran                                        From: 26/10/2017 to: 28/10/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 15/12/2017 to: 18/12/2017 6th Arab and Southern European Countries Masterclass in Clinical Oncology, Limassol, Cyprus                                        From: 22/01/2018 to: 26/01/2018 University Post-graduate Course - Clinical Oncology: Sarcomas, Milan, Italy                                        From: 05/02/2018 to: 09/02/2018 University Post-graduate Course - Clinical Oncology: Head & neck cancers, Milan, Italy                                        From: 23/02/2018 to: 25/02/2018 3rd ESO Masterclass in Cancer Patient Advocacy , Lisbon, Portugal                                        From: 24/03/2018 to: 29/03/2018 17th ESO-ESMO Masterclass in Clinical Oncology, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 24/03/2018 to: 29/03/2018 11th ESO-EONS Masterclass in Oncology Nursing , Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 18/04/2018 to: 22/04/2018 4th ESO-ESMO Latin-American Masterclass in Clinical Oncology, Mexico City, Mexico                                        From: 17/05/2018 to: 18/05/2018 8th ESO-CNIO Familial Cancer Conference, Madrid, Spain                                        From: 18/05/2018 to: 22/05/2018 3rd Masterclass on Systematic Reviews in Cancer Care, Guidelines and Research, Belfast, United Kingdom                                        From: 15/06/2018 to: 20/06/2018 5th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, Belgrade, Republic of Serbia                                        From: 16/06/2018 to: 21/06/2018 7th ESO-SIOP Europe Masterclass in Paediatric Oncology, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 19/07/2018 to: 25/07/2018 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 27/08/2018 to: 07/09/2018 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Poznan, Poland                                        From: 20/09/2018 to: 22/09/2018 1st ESO-EONS Eastern Europe and Balkan Region Masterclass in Oncology Nursing, Budapest, Hungary                                        From: 27/09/2018 to: 29/09/2018 Update Skills in Head and Neck Surgery and Oncology, Leipzig, Germany                                        From: 6/10/2018 to: 8/10/2018 4th ESO-ESMO Breast Cancer in Young Women International Conference, Lugano, Switzerland                                        From: 30/10/2018 to: 31/10/2018 10th Clinical Oncology Update - Onkologia 2018, Krakow, Poland                                        From: 10/11/2018 to: 13/11/2018 ESO-ASCO Masterclass in Clinical Oncology, Yerevan, Armenia
Agenda


The first day of WOF was dedicated to discussion presentations from leading international experts on key aspects of cancer control across the globe. The second day focused on developing strategies that can turn the tide against cancer.


26 OCTOBER 2012  
 
Opening
Welcome by Franco Cavalli, Chair, ESO Scientific Committee, Bellinzona, Switzerland
Opening address by Umberto Veronesi, ESO Founder, Milan, Italy
   
   
Mapping the global cancer burden: who’s most at risk from cancer and why?
Session leader: John Ioannidis, Professor of Medicine, Statistics, Health Research and Policy, Stanford University School of Medicine, Stanford, USA
Presenter: Paolo Vineis, Chair in Environmental Epidemiology, School of Public Health, Imperial College, London, UK
Devil’s advocate: Clifton Leaf, Staff Editor, The New York Times, New York, USA
   
Outwitting cancer: the big questions that remain unanswered
Session leader: Julio Celis, Associate Scientific Director of the Danish Cancer Society Research Center, Copenhagen, Denmark
Presenter: Douglas Hanahan, Director, Swiss Institute for Experimental Cancer Research, Swiss Federal Institute of Technology, Lausanne, Switzerland
Devil’s advocate: Rabiya S. Tuma, Science Writer, The Economist, San Francisco, USA
   

Survival trends: a worldwide look at who’s winning and who’s losing
Session leader: Lex Eggermont, General Director Gustave Roussy Cancer Institute, Villejuif, France
Presenter: Michel Coleman, Professor of Epidemiology and Vital Statistics, London School of Hygiene and Tropical Medicine, UK
Devil’s advocate: Ulrich Bahnsen, Science Correspondence, Die Zeit, Germany

   
Changing cancer mortality
Moderator: Franco Cavalli
Presenter: Richard Peto, Professor of Medical Statistics and Epidemiology, University of Oxford, UK
   
Overcoming the divide
Presenter: Felicia Knaul, Director, Harvard Global Equity Initiative, Harvard Medical School, Boston, USA
   
General discussion
Moderator: Franco Cavalli
 
   
27 OCTOBER 2012  
 
What can we learn from the fight against AIDS, TB and Malaria
Moderator: Mary Gospodarowicz, Professor, Department of Radiation Oncology, University of Toronto, Canada and President, International Union for Cancer Control
, Geneva, Switzerland
Presenter: Rifat Atun, Professor of International Health Management, Imperial College, London, United Kingdom
   
Are we winning the war on cancer?
Securing consensus on the WOF Statement
Moderated by Sir Richard Horton, Editor-in-Chief, The Lancet, London, United Kingdom
  
   
Concluding remarks
Franco Cavalli